Merz Aesthetics Taps Gwyneth Paltrow as the Global Face of Xeomin

September 24, 2020

Merz Aesthetics has announced a partnership with Oscar- and Emmy-award-winning actor, author and entrepreneur, Gwyneth Paltrow, for the launch of the company’s first global campaign for Xeomin (incobotulinumtoxinA). Xeomin (pronounced phonetically: Zeo-min) is an FDA-approved anti-wrinkle injection for frown lines that is purified to remove unnecessary proteins. Women have been using Xeomin for nearly 10 years to give wrinkles between the eyebrows a smoother appearance. As the global face of the brand, Paltrow joins Xeomin in standing with women who choose beauty on their own terms and do so with proven products.
Read more at Business Wire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • PracticeQ Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Fresh Clinics Acquires Spakinect
    • Arkansas Nursing Board Comment Deadline Approaching for Medical Aesthetics and IV Hydration Guidance
    • Acquisition Lets AI and Operators Learn From Nearly $2 Billion in Annual Aesthetics Transactions
    • Galderma Celebrates 30 Years of Restylane